Michael R. Preusch

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +6

Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation

Steffen Desch, Anne Freund, Michael Behnes et al. · New England Journal of Medicine · 2021 · 359 citations · Full text

Medicine, Cardiology, Acute Care Medicine +11

Periodontal Disease as a Risk Factor for Ischemic Stroke

Armin Grau, Heiko Becher, Christoph M. Ziegler et al. · Stroke · 2004 · 351 citations

Dentistry, Periodontics, Periodontology +15

Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban

Qianxing Zhou, Florian Bea, Michael R. Preusch et al. · Mediators of Inflammation · 2011 · 125 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The association of gingivitis and periodontitis with ischemic stroke

Christof E. Dörfer, Heiko Becher, Christoph M. Ziegler et al. · Journal Of Clinical Periodontology · 2004 · 117 citations

Dentistry, Periodontics, Periodontology +17